Search

Objectives: In this study, we used the recently developed ultrasound elastography techniques sound touch elastography (STE) and sound touch quantification (STQ) to quantify portal hypertension (PHT) severity in a rat model of carbon tetrachloride (CCl4)‐induced cirrhotic PHT. Methods: In total, 60 rats were used. Various degrees of PHT were established. Liver and spleen stiffness were measured by STE (L‐STE and S‐STE, respectively) and STQ (L‐STQ and S‐STQ, respectively). We measured portal pressure (PP) after ultrasonographic examination. The performance of the STE and STQ parameters in the identification of PHT was evaluated using receiver operating characteristic (ROC) analyses. Results: Liver and spleen stiffness measurements obtained with STE and STQ correlated positively with the PP (r = 0.566–0.882, all P <.001). The areas under ROC curves for L‐STE, S‐STE, L‐STQ, and S‐STQ values were 0.931 (95% confidence interval [CI], 0.847–1.000), 0.982 (95% CI, 0.956–1.000), 0.796 (95% CI, 0.680–0.912), and 0.925 (95% CI, 0.858–0.993), respectively, for PP ≥5 mmHg; 0.937 (95% CI, 0.865–1.000), 0.938 (95% CI, 0.864–1.000), 0.967 (95% CI, 0.923–1.000), and 0.960 (95% CI, 0.897–1.000), respectively, for PP ≥10 mmHg; and 0.954 (95% CI, 0.897–1.000), 0.790 (95% CI, 0.652–0.928), 0.808 (95% CI, 0.680–0.935), and 0.740 (95% CI, 0.595–0.885), respectively, for PP ≥12 mmHg. Conclusions: STE and STQ are reliable noninvasive tools for the assessment of PHT severity, especially for PP ≥10 mmHg, in a rat model of CCl4‐induced cirrhotic PHT. [ABSTRACT FROM AUTHOR]

Two-dimensional shear wave elastography (2D-SWE) has recently been proposed to detect clinically significant portal hypertension (CSPH), we aimed to perform a meta-analysis based on the published data to assess the diagnostic accuracy of 2D-SWE for detecting CSPH. Literature databases were searched up until 1 August 2021. The summary area under receiver operating characteristics curve (AUROC), the summary diagnostic odds ratio (DOR), and the summary sensitivity and specificity were used to examine the accuracy of 2D-SWE for evaluating CSPH. Heterogeneity was explored using meta-regression. Finally 9 studies with 956 patients were included in this study for evaluation and meta-analysis. 2D-SWE showed good diagnostic performance for detecting CSPH with a summary sensitivity of 83% (95% confidence interval [CI]: 76%-88%) and summary specificity of 78% (95% CI: 65%-87%); the summary AUROC was 0.88 (95% CI: 0.84–0.90). Summary positive likelihood ratio (LR), negative LR, and DOR of 2D-SWE for detecting CSPH were 3.7 (95% CI: 2.4–5.9), 0.22 (95% CI: 0.16–0.30), and 17 (95% CI: 10–29), respectively. 2D-SWE showed good performance in diagnosing CSPH and can be considered as an important and noninvasive adjunctive approach in the management of patients with CSPH. [ABSTRACT FROM AUTHOR]

Background: Impaired respiratory function caused by respiratory muscle dysfunction is one of the common consequences of chronic obstructive pulmonary disease (COPD). In this study, two-dimensional shear wave elastography (2D-SWE) was used to measure diaphragm stiffness (DS) and intercostal muscle stiffness (IMS) in patients with COPD; in addition, the value of 2D-SWE in evaluating respiratory function was determined.Methods: In total, 219 consecutive patients with COPD and 20 healthy adults were included. 2D-SWE was used to measure the DS and IMS, and lung function was also measured. The correlation between respiratory muscle stiffness and lung function and the differences in respiratory muscle stiffness in COPD patients with different severities were analysed.Results: 2D-SWE measurements of the DS and IMS presented with high repeatability and consistency, with ICCs of 0.756 and 0.876, respectively, and average differences between physicians of 0.10 ± 1.61 and 0.07 ± 1.65, respectively. In patients with COPD, the DS and IMS increased with disease severity (F1 = 224.50, F2 = 84.63, P < 0.001). In patients with COPD, the correlation with the forced expiratory volume in one second (FEV1)/forced vital capacity (FVC), predicted FEV1% value, residual volume (RV), total lung capacity (TLC), RV/TLC, functional residual capacity (FRC) and inspiratory capacity (IC) of DS (r1=-0.81, r2=-0.63, r3 = 0.65, r4 = 0.54, r5 = 0.60, r6 = 0.72 and r7=-0.41, respectively; P < 0.001) was stronger than that of IMS (r1=-0.76, r2=-0.57, r3 = 0.57, r4 = 0.47, r5 = 0.48, r6 = 0.60 and r7=-0.33, respectively; P < 0.001).Conclusion: 2D-SWE has potential for use in evaluating DS and IMS. A specific correlation was observed between respiratory muscle stiffness and lung function. With the worsening of the severity of COPD and the progression of lung function impairment, the DS and IMS gradually increased. [ABSTRACT FROM AUTHOR]

Aim: This study assessed the diagnostic performance of liver stiffness measurement (LSM) in detecting liver fibrosis in paediatric patients with non‐alcoholic fatty liver disease (NAFLD) through meta‐analysis. Methods: Online database searches of PubMed, EMBASE, the Cochrane Library and the Web of Science were conducted for studies that evaluated the performance of LSM for diagnosing liver fibrosis in paediatric patients with NAFLD until 1 January 2021. The Quality Assessment of Diagnostic Accuracy Studies‐2 (QUADAS‐2) tool was used to assess the quality of the included studies. Three measures were used to assess the performance of LSM for detecting liver fibrosis in paediatric patients with NAFLD, including the summary sensitivities and specificities, the summary area under the receiver operating characteristic curves and the summary diagnostic odds ratios. Results: Our final data included seven studies with a total of 436 paediatric patients with NAFLD for meta‐analysis. The overall prevalence of mild fibrosis, significant fibrosis, advanced fibrosis and cirrhosis was 66.3, 31.5, 14.9 and 1.2%, respectively. The summary sensitivity, specificity and area under the receiver operating characteristic values of LSM were 80, 92 and 0.94 for the prediction of mild fibrosis; 91, 97 and 0.98 for the prediction of significant fibrosis; and 89, 93 and 0.96 for the prediction of advanced fibrosis, respectively. Conclusion: Liver stiffness measurement exhibited good diagnostic performance in predicting liver fibrosis and can be used as a non‐invasive tool in the management of paediatric patients with non‐alcoholic fatty liver disease. [ABSTRACT FROM AUTHOR]